As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
New collection: Advances in CAR-T immunotherapy
BMC Biotechnology and BMC Cancer together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. Click to read more.
BMC Series Focus Issue
July: Inflammation
To celebrate World Allergy Week 2020, the BMC Series is proud to present July’s focus issue dedicated to inflammation. Browse our biology, chemistry and medical titles for insight into recent research in the field, including allergy, autoimmune and inflammatory conditions.
Featured Article
Back to top 
Lentiviral system for genome editing
In this article the authors demonstrate a new lentivirus-driven method for genome editing of Salmon cells. Read the full article here.
Articles
-
-
Functional expression of a novel methanol-stable esterase from Geobacillus subterraneus DSM13552 for biocatalytic synthesis of cinnamyl acetate in a solvent-free system
-
Efficient CRISPR/Cas9 genome editing in a salmonid fish cell line using a lentivirus delivery system
-
Loop-mediated isothermal amplification (LAMP) reaction as viable PCR substitute for diagnostic applications: a comparative analysis study of LAMP, conventional PCR, nested PCR (nPCR) and real-time PCR (qPCR) based on Entamoeba histolytica DNA derived from faecal sample
-
An improved quantitative real-time polymerase chain reaction technology for Helicobacter pylori detection in stomach tissue and its application value in clinical precision testing
-
An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol
-
FastCloning: a highly simplified, purification-free, sequence- and ligation-independent PCR cloning method
-
Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies
-
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
-
Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells
Aims and scope
BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.
The journal welcomes submissions in these broad areas of research:
Applied immunology
Cellular, tissue and whole organism biotechnology
Drug discovery and delivery
Environmental biotechnology
Food and nutritional biotechnology
Genetic engineering
Mathematical modeling and statistics in biology
Methods and technological advances in biotechnology
Microbial biotechnology
Plant and agricultural biotechnology
Systems and synthetic biology
To read the full scope of the journal, click here.
Read MoreBMC Biotechnology is recruiting new Associate Editors
@Pixabay
Learn more about the role and requirements here and if interested please complete the accompanying Application form
Read MoreEditor
- Akila Sridhar, BioMed Central, UK
Manuscript Editor
- Anna Melidoni, BioMed Central, UK
Assistant Editor
- Lauren McMillan, BioMed Central, UK
Section Editors
- Joaquim M Cabral, Instituto Superior Tecnico
- Dennis Claessen, Leiden University
- Peter J Punt, TNO Microbiology & Systems Biology/Leiden University
- Marko Radic, University of Tennessee
- John J Rossi, Beckman Research Institute City of Hope
- Igor Stagljar, University of Toronto
- Hyung Joon Cha, Pohang University of Science and Technology
- Ting Lu, University of Illinois at Urbana-Champaign
Peter Punt
Peter J. Punt, PhD is Chief Technology Officer of Dutch DNA Biotech BV, a fungal biotechnology technology provider and contract research company situated in the Netherlands. In 2008 he was appointed at Leiden University in the chair of Industrial Biotechnology He joined BMC Biotechnology as a Section Editor in 2012.
BMC Series Blog
Follow
2019 Journal Metrics
-
Citation Impact
2.312 - 2-year Impact Factor
2.777 - 5-year Impact Factor
0.865 - Source Normalized Impact per Paper (SNIP)
0.962 - SCImago Journal Rank (SJR)
Usage
715,050 Downloads
250 Altmetric Mentions
